IP Library › Granted Patent US 12,534,759
Granted Patent B2
US 12,534,759 · App. 18/738,910 · Granted Jan 27, 2026

Safe sequencing system

Inventors: Bert Vogelstein (Baltimore, MD); Kenneth W. Kinzler (Frankford, DE); Nickolas Papadopoulos (Towson, MD); Isaac A Kinde (Beaumont, CA)
Assignee: The Johns Hopkins University
C12Q1/6874C12Q1/6806C12Q1/6869C12Q1/6876C12Q2525/179C12Q2525/191C12Q2563/179C12Q2600/158
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,534,759
App. No.
18/738,910
Granted
Jan 27, 2026
Kind
B2
Abstract

The identification of mutations that are present in a small fraction of DNA templates is essential for progress in several areas of biomedical research. Though massively parallel sequencing instruments are in principle well-suited to this task, the error rates in such instruments are generally too high to allow confident identification of rare variants. We here describe an approach that can substantially increase the sensitivity of massively parallel sequencing instruments for this purpose. One example of this approach, called “Safe-SeqS” for (Safe-Sequencing System) includes (i) assignment of a unique identifier (UID) to each template molecule; (ii) amplification of each uniquely tagged template molecule to create UID-families; and (iii) redundant sequencing of the amplification products. PCR fragments with the same UID are truly mutant (“super-mutants”) if ≥95% of them contain the identical mutation. We illustrate the utility of this approach for determining the fidelity of a polymerase, the accuracy of oligonucleotides synthesized in vitro, and the prevalence of mutations in the nuclear and mitochondrial genomes of normal cells.

Claims (25)

1 . A method comprising:

a) attaching paired-end adapters to first and second ends of an initial double-stranded template nucleic acid molecule (IDSTNM) having top and bottom strands to form an adapted fragment, wherein a first endogenous UID is at said first end of said IDSTNM and a second endogenous UID is at said second end of said IDSTNM;

b) amplifying said adapted fragment such that a plurality of double-stranded amplicons are generated that each comprise a first paired-end adapter at one end and a second paired-end adapter at the other end that is different from said first paired-end adapter,

c) subjecting said plurality of double-stranded amplicons to paired-end sequencing on a massively parallel sequencer using a first primer to said first paired-end adapter and a second primer to said second paired-end adapter to generate the following reads:

i) first primer top strand reads and second primer top strand reads, and

ii) first primer bottom strand reads and second primer bottom strand;

d) differentiating said top and bottom strands of said IDSTNM based on the observed orientation and order of said first and second endogenous UIDs as they appear in said reads when sequence information is obtained from said paired-end sequencing;

e) grouping said reads by chromosome position of said first and second endogenous UIDs yielding:

i) a first family comprising said first primer top strand reads and said second primer top strand reads, and

ii) a second family comprising said first primer bottom strand reads and said second primer bottom strand reads;

f) comparing nucleotide sequences between members of said first family, and comparing nucleotide sequences between members of said second family; and

g) identifying a nucleotide sequence as accurately representing said top strand or bottom strand of said initial double-stranded template molecule when at least 50% of members of said first family, or said second family, contain the sequence.

2 . The method of claim 1 , wherein said first and second endogenous UIDs are 2 to 1000 bases in length.

3 . The method of claim 1 , wherein said first and second endogenous UIDs are 4 to 400 bases in length.

4 . The method of claim 1 , wherein said at least 50% is at least 70%.

5 . The method of claim 1 , wherein said attaching adapters is performed by ligation.

6 . The method of claim 1 , wherein said amplification employs primers complementary to at least a portion of said paired-end adapters.

7 . The method of claim 6 , wherein said primers comprise an indexing and/or grafting sequence.

8 . The method of claim 1 , wherein said initial double-stranded template nucleic acid molecule is from a human sample.

9 . The method of claim 8 , wherein said human sample comprises tissue.

10 . The method of claim 1 , wherein said plurality of double-stranded amplicons are subjected to an enrichment step where it is captured by a complementary oligonucleotide prior to said paired-end sequencing.

11 . The method of claim 1 , wherein said differentiating said top and bottom strands of said IDSTNM is further based on the observed orientation and order of at least part of said first and second paired-end adapters.

12 . The method of claim 1 , wherein said members of said first family comprise more than two members, and wherein said members of said second family comprise more than two members.

13 . The method of claim 1 , wherein said members of said first family comprise more than five members, and wherein said members of said second family comprise more than five members.

14 . The method of claim 1 , wherein said members of said first family comprise more than ten members, and wherein said members of said second family comprise more than ten members.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2024
From: VOGELSTEIN, BERT; KINZLER, KENNETH W.; PAPADOPOULOS, NICKOLAS; KINDE, ISAAC A.
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 067689/0251 →
Continuity (10)
Continuation 18519727 · Nov 27, 2023
Continuation 17837591 · Jun 10, 2022
Continuation 17324380 · May 19, 2021
Continuation 15240034 · Aug 18, 2016
Division 15090773 · Apr 5, 2016
Division 14814030 · Jul 30, 2015
Division 14111715
Provisional Application 61484482 · May 10, 2011
Provisional Application 61476150 · Apr 15, 2011
Related Publication 20240309449A1 · Sep 19, 2024
References Cited (400)
US 5308751A · Ohkawa et al. · 1994 [cited by applicant]
US 5750341A · Macevicz · 1998 [cited by applicant]
US 6090935A · Breivik et al. · 2000 [cited by applicant]
US 6156504A · Gocke et al. · 2000 [cited by applicant]
US 6248521B1 · Once · 2001 [cited by applicant]
US 6306597B1 · Macevicz · 2001 [cited by applicant]
US 6361940B1 · Van Ness et al. · 2002 [cited by applicant]
US 6514736B1 · Erlich et al. · 2003 [cited by applicant]
US 6576420B1 · Carson et al. · 2003 [cited by applicant]
US 6686157B2 · Ward et al. · 2004 [cited by applicant]
US 6746845B2 · Kinzler et al. · 2004 [cited by applicant]
US 6815212B2 · Ness et al. · 2004 [cited by applicant]
US 6890764B2 · Chee et al. · 2005 [cited by applicant]
US 6942968B1 · Dickinson et al. · 2005 [cited by applicant]
US 6977153B2 · Kumar et al. · 2005 [cited by applicant]
US 7056660B1 · Diehl et al. · 2006 [cited by applicant]
US 7060431B2 · Chee et al. · 2006 [cited by applicant]
US 7115400B1 · Adessi et al. · 2006 [cited by applicant]
US 7211390B2 · Rothberg et al. · 2007 [cited by applicant]
US 7232656B2 · Balsubramanian et al. · 2007 [cited by applicant]
US 7264929B2 · Rothberg et al. · 2007 [cited by applicant]
US 7323305B2 · Leamon et al. · 2008 [cited by applicant]
US 7323310B2 · Peters et al. · 2008 [cited by applicant]
US 7499806B2 · Kermani et al. · 2009 [cited by applicant]
US 7601499B2 · Berka et al. · 2009 [cited by applicant]
US 7682790B2 · Hollander et al. · 2010 [cited by applicant]
US 7683035B1 · Erbacher et al. · 2010 [cited by applicant]
US 7700286B2 · Stroun et al. · 2010 [cited by applicant]
US 7702468B2 · Chinitz et al. · 2010 [cited by applicant]
US 7704687B2 · Wang et al. · 2010 [cited by applicant]
US 7745125B2 · Gelfand et al. · 2010 [cited by applicant]
US 7754429B2 · Rigatti et al. · 2010 [cited by applicant]
US 7776531B1 · Black et al. · 2010 [cited by applicant]
US 7811759B2 · Han · 2010 [cited by applicant]
US 7899626B2 · Kruglyak et al. · 2011 [cited by applicant]
US 7901897B2 · Stuelpnagel et al. · 2011 [cited by applicant]
US 7948015B2 · Rothberg et al. · 2011 [cited by applicant]
US 7957913B2 · Chinitz et al. · 2011 [cited by applicant]
US 7977108B2 · Newhouse et al. · 2011 [cited by applicant]
US 8021888B2 · Mohammed et al. · 2011 [cited by applicant]
US 8026053B2 · Samuels et al. · 2011 [cited by applicant]
US 8043834B2 · Abarzua et al. · 2011 [cited by applicant]
US 8076074B2 · Mohammed · 2011 [cited by applicant]
US 8093063B2 · Albitar · 2012 [cited by applicant]
US 8150626B2 · Fan et al. · 2012 [cited by applicant]
US 8182989B2 · Bignell et al. · 2012 [cited by applicant]
US 8190373B2 · Huang et al. · 2012 [cited by applicant]
US 8288103B2 · Oliphant et al. · 2012 [cited by applicant]
US 8298767B2 · Brenner et al. · 2012 [cited by applicant]
US 8343718B2 · Van Der Werf et al. · 2013 [cited by applicant]
US 8372637B2 · Hollander · 2013 [cited by applicant]
US 8383345B2 · Shendure et al. · 2013 [cited by applicant]
US 8481292B2 · Casbon et al. · 2013 [cited by applicant]
US 8492089B2 · Owen et al. · 2013 [cited by applicant]
US 8658572B2 · Albert et al. · 2014 [cited by applicant]
US 8728732B2 · Guerrero Preston et al. · 2014 [cited by applicant]
US 8741630B2 · Dickinson et al. · 2014 [cited by applicant]
US 8741811B2 · Lo et al. · 2014 [cited by applicant]
US 8765419B2 · Hirschbein et al. · 2014 [cited by applicant]
US 8822158B2 · Froehlich et al. · 2014 [cited by applicant]
US 8835358B2 · Fodor et al. · 2014 [cited by applicant]
US 8865410B2 · Shendure et al. · 2014 [cited by applicant]
US 8871687B2 · Strom · 2014 [cited by applicant]
US 8877436B2 · Eder et al. · 2014 [cited by applicant]
US 8911942B2 · Mohammed et al. · 2014 [cited by applicant]
US 8962250B2 · Stanley · 2015 [cited by applicant]
US 9012149B2 · Kim et al. · 2015 [cited by applicant]
US 9029103B2 · Rigatti et al. · 2015 [cited by applicant]
US 9045796B2 · Gunderson et al. · 2015 [cited by applicant]
US 9051606B2 · Liu et al. · 2015 [cited by applicant]
US 9074206B2 · Wu et al. · 2015 [cited by applicant]
US 9085798B2 · Chee et al. · 2015 [cited by applicant]
US 9115410B2 · Nazarenko et al. · 2015 [cited by applicant]
US 9128861B2 · Bartha et al. · 2015 [cited by applicant]
US 9163283B2 · Chee et al. · 2015 [cited by applicant]
US 9222134B2 · Mann · 2015 [cited by applicant]
US 9228234B2 · Rabinowitz et al. · 2016 [cited by applicant]
US 9233125B2 · Davila et al. · 2016 [cited by applicant]
US 9238832B2 · Will et al. · 2016 [cited by applicant]
US 9279146B2 · Gupta et al. · 2016 [cited by applicant]
US 9340830B2 · Lipson et al. · 2016 [cited by applicant]
US 9382581B2 · Froehner et al. · 2016 [cited by applicant]
US 9389234B2 · Von Hoff et al. · 2016 [cited by applicant]
US 9399794B2 · Liu · 2016 [cited by applicant]
US 9404156B2 · Hicks et al. · 2016 [cited by applicant]
US 9410206B2 · Hoon et al. · 2016 [cited by applicant]
US 9410956B1 · Cheng · 2016 [cited by applicant]
US 9422593B2 · Rothmann et al. · 2016 [cited by applicant]
US 9424392B2 · Rabinowitz et al. · 2016 [cited by applicant]
US 9441267B2 · Gunderson et al. · 2016 [cited by applicant]
US 9453258B2 · Kain et al. · 2016 [cited by applicant]
US 9476095B2 · Vogelstein et al. · 2016 [cited by applicant]
US 9487823B2 · Lasken et al. · 2016 [cited by applicant]
US 9487829B2 · Vogelstein et al. · 2016 [cited by applicant]
US 9546399B2 · Amorese et al. · 2017 [cited by applicant]
US 9546404B2 · Sanders et al. · 2017 [cited by applicant]
US 9556491B2 · Hoon · 2017 [cited by applicant]
US 9567640B2 · Hoon · 2017 [cited by applicant]
US 9574234B2 · Straus et al. · 2017 [cited by applicant]
US 9587273B2 · Stuelpnagel et al. · 2017 [cited by applicant]
US 9593366B2 · Nazarenko et al. · 2017 [cited by applicant]
US 9598731B2 · Talasaz · 2017 [cited by applicant]
US 9670530B2 · Kostem et al. · 2017 [cited by applicant]
US 9689047B2 · O'Neil et al. · 2017 [cited by applicant]
US 9702004B2 · Van Eijk et al. · 2017 [cited by applicant]
US 9708655B2 · Mandell et al. · 2017 [cited by applicant]
US 9745632B2 · Parr et al. · 2017 [cited by applicant]
US 9752188B2 · Schmitt et al. · 2017 [cited by applicant]
US 9760530B2 · Harsha et al. · 2017 [cited by applicant]
US 9783847B2 · Chee · 2017 [cited by applicant]
US 9783854B2 · Sanders et al. · 2017 [cited by applicant]
US 9792403B2 · Sun et al. · 2017 [cited by applicant]
US 9797000B2 · Lowe et al. · 2017 [cited by applicant]
US 9816139B2 · Breen · 2017 [cited by applicant]
US 9828672B2 · Varadarajan et al. · 2017 [cited by applicant]
US 9834822B2 · Talasaz et al. · 2017 [cited by applicant]
US 9873908B2 · Gupta et al. · 2018 [cited by applicant]
US 9879312B2 · Steemers et al. · 2018 [cited by applicant]
US 9902992B2 · Talasaz et al. · 2018 [cited by applicant]
US 9914973B2 · Cheng · 2018 [cited by applicant]
US 9920366B2 · Eltoukhy et al. · 2018 [cited by applicant]
US 9944924B2 · Rigatti et al. · 2018 [cited by applicant]
US 9957570B2 · Mori et al. · 2018 [cited by applicant]
US 9965585B2 · Lo et al. · 2018 [cited by applicant]
US 9992598B2 · Reiche · 2018 [cited by applicant]
US 10011826B2 · Hollander et al. · 2018 [cited by applicant]
US 10011870B2 · Zimmermann et al. · 2018 [cited by applicant]
US 10017759B2 · Kaper et al. · 2018 [cited by applicant]
US 10023904B2 · Villahermosa Jaen et al. · 2018 [cited by applicant]
US 10023917B2 · Buettner et al. · 2018 [cited by applicant]
US 10041127B2 · Talasaz · 2018 [cited by applicant]
US 10102337B2 · Scolnick et al. · 2018 [cited by applicant]
US 10113196B2 · Ryan et al. · 2018 [cited by applicant]
US 10113199B2 · Morin et al. · 2018 [cited by applicant]
US 10125399B2 · West · 2018 [cited by applicant]
US 10208338B2 · Makarov et al. · 2019 [cited by applicant]
US 10227652B2 · Rabinowitz et al. · 2019 [cited by applicant]
US 10240202B2 · Rabinowitz et al. · 2019 [cited by applicant]
US 10266893B2 · Rabinowitz et al. · 2019 [cited by applicant]
US 10388403B2 · Rava et al. · 2019 [cited by applicant]
US 10422006B2 · Samuels et al. · 2019 [cited by applicant]
US 10450611B2 · West et al. · 2019 [cited by applicant]
US 10457995B2 · Talasaz · 2019 [cited by applicant]
US 10494678B2 · Talasaz · 2019 [cited by applicant]
US 10501793B2 · Chee et al. · 2019 [cited by applicant]
US 10501810B2 · Talasaz · 2019 [cited by applicant]
US 10522242B2 · Rabinowitz et al. · 2019 [cited by applicant]
US 10526658B2 · Babiarz et al. · 2020 [cited by applicant]
US 10538759B2 · Stuelpnagel et al. · 2020 [cited by applicant]
US 10538814B2 · Babiarz et al. · 2020 [cited by applicant]
US 10557172B2 · Babiarz et al. · 2020 [cited by applicant]
US 10577601B2 · Shendure et al. · 2020 [cited by applicant]
US 10590482B2 · Ryan et al. · 2020 [cited by applicant]
US 10597653B2 · Sabot et al. · 2020 [cited by applicant]
US 10619214B2 · Lo et al. · 2020 [cited by applicant]
US 10655180B2 · Babiarz et al. · 2020 [cited by applicant]
US 10704085B2 · Talasaz et al. · 2020 [cited by applicant]
US 10704086B2 · Talasaz et al. · 2020 [cited by applicant]
US 10704105B2 · Samuels et al. · 2020 [cited by applicant]
US 10704108B2 · Vogelstein et al. · 2020 [cited by applicant]
US 10731220B2 · Babiarz et al. · 2020 [cited by applicant]
US 10732220B2 · Tamura et al. · 2020 [cited by applicant]
US 10783364B2 · Gao · 2020 [cited by applicant]
US 10787713B2 · Samuels et al. · 2020 [cited by applicant]
US 10801063B2 · Eltoukhy et al. · 2020 [cited by applicant]
US 10822663B2 · Talasaz · 2020 [cited by applicant]
US 11180803B2 · Vogelstein et al. · 2021 [cited by applicant]
US 11299783B2 · West et al. · 2022 [cited by applicant]
US 11408037B2 · Babiarz et al. · 2022 [cited by applicant]
US 11453913B2 · Vogelstein et al. · 2022 [cited by applicant]
US 11479807B2 · Kennedy et al. · 2022 [cited by applicant]
US 20020119448A1 · Sorge et al. · 2002 [cited by applicant]
US 20020160404A1 · Dietmaier et al. · 2002 [cited by applicant]
US 20030148335A1 · Shen et al. · 2003 [cited by applicant]
US 20040209299A1 · Pinter et al. · 2004 [cited by applicant]
US 20040259105A1 · Fan et al. · 2004 [cited by applicant]
US 20050136405A1 · Linder et al. · 2005 [cited by applicant]
US 20050153313A1 · Endege et al. · 2005 [cited by applicant]
US 20050244847A1 · Domanico et al. · 2005 [cited by applicant]
US 20060127918A1 · Mohammed et al. · 2006 [cited by applicant]
US 20060263789A1 · Kincaid · 2006 [cited by applicant]
US 20060292576A1 · Albitar et al. · 2006 [cited by applicant]
US 20070020640A1 · McCloskey · 2007 [cited by applicant]
US 20070077570A1 · Lao et al. · 2007 [cited by applicant]
US 20070269805A1 · Hogers · 2007 [cited by applicant]
US 20080160580A1 · Adessi et al. · 2008 [cited by applicant]
US 20080286795A1 · Kawashima et al. · 2008 [cited by applicant]
US 20090088328A1 · Mohammed et al. · 2009 [cited by applicant]
US 20090105081A1 · Rodesch et al. · 2009 [cited by applicant]
US 20090105959A1 · Braverman et al. · 2009 [cited by applicant]
US 20090215062A1 · Lee · 2009 [cited by applicant]
US 20090233802A1 · Bignell · 2009 [cited by applicant]
US 20090298075A1 · Travers et al. · 2009 [cited by applicant]
US 20090298187A1 · Nazarenko et al. · 2009 [cited by applicant]
US 20100041048A1 · Diehl et al. · 2010 [cited by applicant]
US 20100113758A1 · Wilmer et al. · 2010 [cited by applicant]
US 20100127186A1 · Bykanov et al. · 2010 [cited by applicant]
US 20100129874A1 · Mitra et al. · 2010 [cited by applicant]
US 20100248991A1 · Roesler et al. · 2010 [cited by applicant]
US 20100273219A1 · May et al. · 2010 [cited by applicant]
US 20110152111A1 · Fan et al. · 2011 [cited by applicant]
US 20110217309A1 · Buck et al. · 2011 [cited by applicant]
US 20110319415A1 · Thomas et al. · 2011 [cited by applicant]
US 20120010091A1 · Linnarson · 2012 [cited by applicant]
US 20120065081A1 · Chee · 2012 [cited by applicant]
US 20120156753A1 · Jendrisak et al. · 2012 [cited by applicant]
US 20120225428A1 · Beck et al. · 2012 [cited by applicant]
US 20130059741A1 · Weiner · 2013 [cited by applicant]
US 20130266938A1 · Will · 2013 [cited by applicant]
US 20140011199A1 · Speiser et al. · 2014 [cited by applicant]
US 20140038837A1 · Fung et al. · 2014 [cited by applicant]
US 20140050788A1 · Daniel et al. · 2014 [cited by applicant]
US 20140066317A1 · Talasaz · 2014 [cited by applicant]
US 20140128270A1 · Nakao · 2014 [cited by applicant]
US 20140271635A1 · Brogdon et al. · 2014 [cited by applicant]
US 20140336996A1 · Sun et al. · 2014 [cited by applicant]
US 20140364323A1 · Fan et al. · 2014 [cited by applicant]
US 20150011416A1 · Lei et al. · 2015 [cited by applicant]
US 20150024948A1 · Dugas et al. · 2015 [cited by applicant]
US 20150051085A1 · Vogelstein et al. · 2015 [cited by applicant]
US 20150087535A1 · Patel · 2015 [cited by applicant]
US 20150093756A1 · Wolff et al. · 2015 [cited by applicant]
US 20150176071A1 · Fisher et al. · 2015 [cited by applicant]
US 20150197787A1 · Welder et al. · 2015 [cited by applicant]
US 20150225775A1 · Satya · 2015 [cited by applicant]
US 20150252415A1 · Vogelstein et al. · 2015 [cited by applicant]
US 20150275267A1 · O'Neil et al. · 2015 [cited by applicant]
US 20150307947A1 · Basu et al. · 2015 [cited by applicant]
US 20150324519A1 · Liu · 2015 [cited by applicant]
US 20150360193A1 · Fan et al. · 2015 [cited by applicant]
US 20160017320A1 · Wang et al. · 2016 [cited by applicant]
US 20160026758A1 · Jabara et al. · 2016 [cited by applicant]
US 20160048564A1 · Bassett, Jr. et al. · 2016 [cited by applicant]
US 20160092630A1 · Chen et al. · 2016 [cited by applicant]
US 20160194404A1 · June et al. · 2016 [cited by applicant]
US 20160251704A1 · Talasaz et al. · 2016 [cited by applicant]
US 20160273049A1 · Velculescu et al. · 2016 [cited by applicant]
US 20160281154A1 · So et al. · 2016 [cited by applicant]
US 20160319345A1 · Gnerre et al. · 2016 [cited by applicant]
US 20160374330A1 · Grolz · 2016 [cited by applicant]
US 20170009287A1 · Brastaad et al. · 2017 [cited by applicant]
US 20170039328A1 · Kathleen et al. · 2017 [cited by applicant]
US 20170058332A1 · Kermani et al. · 2017 [cited by applicant]
US 20170061072A1 · Kermani et al. · 2017 [cited by applicant]
US 20170101676A1 · Teng et al. · 2017 [cited by applicant]
US 20170137876A1 · Rigatti et al. · 2017 [cited by applicant]
US 20170141793A1 · Straus et al. · 2017 [cited by applicant]
US 20170165289A1 · Minomi et al. · 2017 [cited by applicant]
US 20170175197A1 · Gatalica et al. · 2017 [cited by applicant]
US 20170183742A1 · Thierry et al. · 2017 [cited by applicant]
US 20170240972A1 · Mokhtari et al. · 2017 [cited by applicant]
US 20170240973A1 · Eltoukhy et al. · 2017 [cited by applicant]
US 20170260590A1 · Eltoukhy et al. · 2017 [cited by applicant]
US 20170314081A1 · Gutin et al. · 2017 [cited by applicant]
US 20170316149A1 · Maston · 2017 [cited by applicant]
US 20170356030A1 · Boyanov et al. · 2017 [cited by applicant]
US 20170356053A1 · Otto et al. · 2017 [cited by applicant]
US 20180002738A1 · Wang et al. · 2018 [cited by applicant]
US 20180002749A1 · Larson et al. · 2018 [cited by applicant]
US 20180016640A1 · Xu et al. · 2018 [cited by applicant]
US 20180023119A1 · Adey et al. · 2018 [cited by applicant]
US 20180037950A1 · Gunderson et al. · 2018 [cited by applicant]
US 20180051329A1 · Elzinga · 2018 [cited by applicant]
US 20180087105A1 · Larson et al. · 2018 [cited by applicant]
US 20180095969A1 · Jung et al. · 2018 [cited by applicant]
US 20180100859A1 · Cardone et al. · 2018 [cited by applicant]
US 20180119216A1 · Jamshidi et al. · 2018 [cited by applicant]
US 20180120291A1 · Eltoukhy et al. · 2018 [cited by applicant]
US 20180135044A1 · Sausen et al. · 2018 [cited by applicant]
US 20180135103A1 · Furlan et al. · 2018 [cited by applicant]
US 20180141020A1 · Gunderson et al. · 2018 [cited by applicant]
US 20180142304A1 · Sanders et al. · 2018 [cited by applicant]
US 20180148716A1 · Heitz et al. · 2018 [cited by applicant]
US 20180155705A1 · Wolf et al. · 2018 [cited by applicant]
US 20180155774A1 · Gunderson et al. · 2018 [cited by applicant]
US 20180163201A1 · Larson · 2018 [cited by applicant]
US 20180171337A1 · O'Neil et al. · 2018 [cited by applicant]
US 20180195131A1 · Mortimer · 2018 [cited by applicant]
US 20180201974A1 · Fraser · 2018 [cited by applicant]
US 20180201992A1 · Wu et al. · 2018 [cited by applicant]
US 20180203974A1 · Venn · 2018 [cited by applicant]
US 20180208999A1 · Lo et al. · 2018 [cited by applicant]
US 20180258490A1 · Wang · 2018 [cited by applicant]
US 20190206510A1 · Jiang et al. · 2019 [cited by applicant]
US 20190256924A1 · Vogelstein et al. · 2019 [cited by applicant]
US 20190287654A1 · Curtis et al. · 2019 [cited by applicant]
US 20200013482A1 · Sikora · 2020 [cited by applicant]
US 20200131568A1 · Talasz et al. · 2020 [cited by applicant]
US 20200157636A1 · Velculescu et al. · 2020 [cited by applicant]
US 20200377956A1 · Vogelstein et al. · 2020 [cited by applicant]
US 20240084381A1 · Vogelstein · 2024 [cited by examiner]
CN 1360059 · 2002 [cited by applicant]
CN 102241772 · 2011 [cited by applicant]
EP 1910560 · 2010 [cited by applicant]
EP 3443119 · 2019 [cited by applicant]
EP 3177740 · 2021 [cited by applicant]
WO WO2001023618 · 2001 [cited by applicant]
WO WO2002012897 · 2002 [cited by applicant]
WO WO2002016649 · 2002 [cited by applicant]
WO WO2002059355 · 2002 [cited by applicant]
WO WO2002099982 · 2002 [cited by applicant]
WO WO2004070007 · 2004 [cited by applicant]
WO WO2007073165 · 2007 [cited by applicant]
WO WO2008030186 · 2008 [cited by applicant]
WO WO2008118877 · 2008 [cited by applicant]
WO WO2009152928 · 2009 [cited by applicant]
WO WO2010028098 · 2010 [cited by applicant]
WO WO2010126614 · 2010 [cited by applicant]
WO WO2010127186 · 2010 [cited by applicant]
WO WO2010141955 · 2010 [cited by applicant]
WO WO2012038839 · 2012 [cited by applicant]
WO WO2012092336 · 2012 [cited by applicant]
WO WO2012142213 · 2012 [cited by applicant]
WO WO2013113816 · 2013 [cited by applicant]
WO WO2013148496 · 2013 [cited by applicant]
WO WO2014183078 · 2014 [cited by applicant]
WO WO2015198074 · 2015 [cited by applicant]
WO WO2016130704 · 2016 [cited by applicant]
WO WO2016135300 · 2016 [cited by applicant]
WO WO2016140974 · 2016 [cited by applicant]
WO WO2016141169 · 2016 [cited by applicant]
WO WO2016170147 · 2016 [cited by applicant]
WO WO2016134136 · 2016 [cited by applicant]
WO WO2016193490 · 2016 [cited by applicant]
WO WO2017019456 · 2017 [cited by applicant]
WO WO2017032808 · 2017 [cited by applicant]
WO WO2017053915 · 2017 [cited by applicant]
WO WO2017085321 · 2017 [cited by applicant]
WO WO2017123316 · 2017 [cited by applicant]
WO WO2017127741 · 2017 [cited by applicant]
WO WO2017132276 · 2017 [cited by applicant]
WO WO2017132438 · 2017 [cited by applicant]
WO WO2017136603 · 2017 [cited by applicant]
WO WO2017151524 · 2017 [cited by applicant]
WO WO2017181134 · 2017 [cited by applicant]
WO WO2017181146 · 2017 [cited by applicant]
WO WO2017181202 · 2017 [cited by applicant]
WO WO2017197027 · 2017 [cited by applicant]
WO WO2017201315 · 2017 [cited by applicant]
WO WO2017205686 · 2017 [cited by applicant]
WO WO2017218512 · 2017 [cited by applicant]
WO WO2018009723 · 2018 [cited by applicant]
WO WO2018013598 · 2018 [cited by applicant]
WO WO2018057770 · 2018 [cited by applicant]
WO WO2018064229 · 2018 [cited by applicant]
WO WO2018064629 · 2018 [cited by applicant]
WO WO2018068014 · 2018 [cited by applicant]
WO WO2018077847 · 2018 [cited by applicant]
WO WO2018081130 · 2018 [cited by applicant]
WO WO2018085862 · 2018 [cited by applicant]
WO WO2018093780 · 2018 [cited by applicant]
WO WO2018111872 · 2018 [cited by applicant]
WO WO2018119399 · 2018 [cited by applicant]
WO WO2018119438 · 2018 [cited by applicant]
WO WO2018119452 · 2018 [cited by applicant]
WO WO2018125892 · 2018 [cited by applicant]
WO WO2018136416 · 2018 [cited by applicant]
WO WO2018093744 · 2018 [cited by applicant]
WO WO2018137826 · 2018 [cited by applicant]
WO WO2018177847 · 2018 [cited by applicant]
WO WO2018204657 · 2018 [cited by applicant]
WO WO2018218113 · 2018 [cited by applicant]
WO WO2020021119 · 2020 [cited by applicant]
Hodges et al., “High definition profiling of mammalian DNA methylation by array capture and single molecule bisulfite sequencing,” Genome Research, vol. 19, pp. 1593-1605. (Year: 2009). [cited by examiner]
Abbosh et al., “Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution”, Nature 545: 446-451, 2017. [cited by applicant]
Abdel-Rahman, “Denosumab versus zoledronic acid to prevent aromatase inhibitors—associated fractures in postmenopausal early breast cancer; a mixed treatment meta-analysis.”, Expert Rev Anticancer Ther 16(8): 885-91, 20… [cited by applicant]
ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 60, Mar. 2005. “Pregestational diabetes mellitus.”, Obstet Gynecol 1 05, 675-685, 2005. [cited by applicant]
Affymetrix Human Genome U133 Plus 2.0 Array, Public on Nov. 7, 2003, Gene Expression Omnibus URL: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GPL570> [Retrieved from the internet Jun. 7, 2018]. [cited by applicant]
Agus et al., “Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth”, Cancer Cell 2: 127-137, 2002. [cited by applicant]
Albert et al., “Direct selection of human genomic loci by microarray hybridization”, Nat. Methods 4: 903-905, 2007. [cited by applicant]
Albertini et al., “In vivo somatic mutations in humans: measurement and analysis.”, Annu Rev Genet 24: 305-326, 1990. [cited by applicant]
AlHilli et al., “Incidence and factors associated with synchronous ovarian and endometrial cancer: a population-based case-control study.”, Gynecologic oncology 125: 109-113, 2012. [cited by applicant]
Alizadeh et al., “The Lymphochip: A Specialized cDNA Microarray for the Genomic-scale Analysis of Gene Expression in Normal and Malignant Lymphocytes,” Cold Spring Harbor Symposia on Quantitative Biology, 1999, vol. LXI… [cited by applicant]
Allegra et al., “American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor r… [cited by applicant]
Allen et al., “Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma.”, Ann Surg 265(1): 185-191, 2017. [cited by applicant]
Allory et al., “Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome”, Eur Urol., 2014, 65:360-366. [cited by applicant]
Al-Shannsi et al., “Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations In Arab patients with colorectal cancer: determination of frequency and distribution pattern,” Journal of Gastroin… [cited by applicant]
Alvarez et al., “Widespread Hypomethylation Occurs Early and Synergizes with Gene Amplification during Esophageal Carcinogenesis”, PLOS Genetics, vol. 7, issue 3, e1001356, 1-14 pp. 2011. [cited by applicant]
Alvarez-Chaver et al., “Proteomics for discovery of candidate colorectal cancer biomarkers”, World J. Gastroenterol. 20(14): 3804-3824, 2014. [cited by applicant]
American Cancer Society, “Can ovarian cancer be found early?”, (Available at http://www.cancer.org/Cancer/OvarianCancer/DetailedGuide/ovariancancer-detection), 4 pages, 2017. [cited by applicant]
American College of Obstetricians and Gynecologists, ACOG Committee Opinion: No. 280, Dec. 2002. “The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer.”, Obstet Gynecol 100, 1413… [cited by applicant]
Andre et al., “Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.”, J Clin Oncol., 2009, 27(19):3109-3116. [cited by applicant]
Anglesio et al., “Cancer-Associated Mutations in Endometriosis without Cancer”, N Engl J Med 376: 1835-1848, 2017. [cited by applicant]
Ansari et al.,“Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma”, Br J Surg., 2017, 104(5): 600-607. [cited by applicant]
Antoni et al., “Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.”, Eur Urol, 2017, 71(1):96-108. [cited by applicant]
Araten et al., A quantitative measurement of the human somatic mutation rate., Cancer Res 65: 8111-8117, 2005. [cited by applicant]
Arbyn et al., “European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition—summary document.”, Ann Oncol 21, 448-458 2010. [cited by applicant]
Arnold et al., “Global burden of cancer attributable to high body-mass index in 2012: a population-based study.”, The Lancet. Oncology 16, 36-46, 2015. [cited by applicant]
Audeh et al., “Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.”, Lancet 376: 245-251, 2010. [cited by applicant]
Australian Office Action in Australian Application No. 2017203206, dated Jan. 23, 2018. [cited by applicant]
Awada et al., “An open-label, dose-escalation study to evaluate the safety and pharmacokinetics of CEP-9722 (a PARP-1 and PARP-2 inhibitor) in combination with gemcitabine and cisplatin in patients with advanced solid t… [cited by applicant]
Baard et al., Diagnostic dilemmas in patients with upper tract urothelial carcinoma., Nat Rev Urol, 14(3), 181-191, 2017. [cited by applicant]
Baehner, “The analytical validation of the Oncotype DX Recurrence Score assay”, Ecancermedicalscience 10: 675, 2016. [cited by applicant]
Bahuva et al., “Morphologic abnormalities are poorly predictive of visceral pain in chronic pancreatitis.”, Pancreas 42(1): 6-10, 2013. [cited by applicant]
Bainbridge et al., “Whole exome capture in solution with 3 Gbp of data” Genome Biology, 11(6): R62, 2010. [cited by applicant]
Balmain et al., “A model for RAS mutation patterns in cancers: finding the sweet spot.,” Nature Reviews, 2018, 18:767-777. [cited by applicant]
Bandiera et al., “Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin Min epithelial ovarian cancer diagnosis.”, Clinical chemistr… [cited by applicant]
Bang et al., “Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised contro… [cited by applicant]
Bansal et al., “Low- and high-grade bladder cancer appraisal via serum-based proteomics approach.”, Clin Chim Acta 436: 97-103, 2014. [cited by applicant]
Bardelli et al., “Liquid Biopsies, What We Do Not Know (Yet)”, Cell Press, 31, 172-179, 2017. [cited by applicant]